Ongoing research has revealed that the existence of cancer stem cells (CSCs) is one of the
biggest obstacles in the current cancer therapy. CSCs make an influential function in tumor …

Cancer stem cells (CSCs) are a minority subset of cancer cells that can drive tumor initiation,
promote tumor progression, and induce drug resistance. CSCs are difficult to eliminate by …

Cancer stem cells (CSCs), also known as tumor-initiating cells, are characterized by an
increased capacity for self-renewal, multipotency, and tumor initiation. While CSCs …

Cancer stem cells (CSCs) have emerged as key contributors to tumor initiation, growth, and
metastasis. In addition, CSCs play a significant role in inducing immune evasion, thereby …

Cancer stem cells (CSCs) are a subgroup of tumor cells that are characterized by their tumor
initiating capacity, low proliferation rate, self-renewal capacity, pluripotency and …

Cancer stem cells (CSCs) are subpopulations of undifferentiated cancer cells within the
tumor bulk that are responsible for tumor initiation, recurrence and therapeutic resistance …

Tumor lesions comprise multiple subpopulations of cells including those endowed with
“stemness” properties. The latter cells are responsible of tumor initiation, metastasis …

Exploration of tumor immunity leads to the development of immune checkpoint inhibitors and
cell-based immunotherapies which improve the clinical outcomes in several tumor types …

Cancer stem cells (CSCs) are self-renewing cells that facilitate tumor initiation, promote
metastasis, and enhance cancer therapy resistance. Transcriptomic analyses across many …

It is becoming increasingly clear that virtually all types of human cancers harbor a small
population of stem-like cancer cells (ie, cancer stem cells, CSCs). These CSCs preexist in …